Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$35,000.00

Biomaterials and Processes for Tissue Engineering

FY 2018-19

Summary
Biomaterials and the devices based on these materials (e.g., tissue-engineered constructs) generate a biological response and it is control of that response, mediated by the biomaterial (or the transplanted cells) that dictate the successful implementation of the device. Our current efforts are directed towards vascularization of tissue engineering constructs to circumvent the size limits imposed by Fick's law of diffusion. In part, our effort is centered on modular tissue engineering, a novel approach that results in uniform, scaleable and vascularised constructs. It is based on small (~400 µm) modules made typically from collagen gel containing embedded cells (e.g., liver cells or pancreatic islets) which are covered with endothelial cells to enable blood and nutrient perfusion. In aim 1, we will prepare module components that incorporate and display instructive cues (using decellularized matrix based hydrogels) to enhance vascularization as well as control cell behavior. We will also produce smaller modules using microfluidics to produce more intimate contact between the newly formed vessels and the transplanted cells. In a second area, will advance a methacrylic acid (MAA) containing copolymer (45% MAA, remainder methyl methacrylate) that induces the formation of new blood vessels. Remarkably, this occurs without additional growth factors or cells. In aim 2, we will synthesize novel MAA copolymers, to be used as coatings or as an injectable gel. *NSERC support is used to provide the fundamental engineering infrastructure to enable the applied or biomedical studies; the biomedical studies fall within the mandate of other agencies.*Canada is aging rapidly, leading to a substantial increase in the demand for technologies that will improve productivity and decrease morbidity and mortality. By providing the means to grow replacement tissues, tissue engineering proposes to shift disease management from treatment of symptoms of a failing organ to functional repair. *
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
9366-2013
Name nom
Sefton, Michael
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2013
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
5
Nb partie
5
Application title
Biomaterials and Processes for Tissue Engineering
Keyword
NSERC
Application summary
Biomaterials and the devices based on these materials (e.g., tissue-engineered constructs) generate a biological response and it is control of that response, mediated by the biomaterial (or the transplanted cells) that dictate the successful implementation of the device. Our current efforts are directed towards vascularization of tissue engineering constructs to circumvent the size limits imposed by Fick's law of diffusion. In part, our effort is centered on modular tissue engineering, a novel approach that results in uniform, scaleable and vascularised constructs. It is based on small (~400 µm) modules made typically from collagen gel containing embedded cells (e.g., liver cells or pancreatic islets) which are covered with endothelial cells to enable blood and nutrient perfusion. In aim 1, we will prepare module components that incorporate and display instructive cues (using decellularized matrix based hydrogels) to enhance vascularization as well as control cell behavior. We will also produce smaller modules using microfluidics to produce more intimate contact between the newly formed vessels and the transplanted cells. In a second area, will advance a methacrylic acid (MAA) containing copolymer (45% MAA, remainder methyl methacrylate) that induces the formation of new blood vessels. Remarkably, this occurs without additional growth factors or cells. In aim 2, we will synthesize novel MAA copolymers, to be used as coatings or as an injectable gel. *NSERC support is used to provide the fundamental engineering infrastructure to enable the applied or biomedical studies; the biomedical studies fall within the mandate of other agencies.*Canada is aging rapidly, leading to a substantial increase in the demand for technologies that will improve productivity and decrease morbidity and mortality. By providing the means to grow replacement tissues, tissue engineering proposes to shift disease management from treatment of symptoms of a failing organ to functional repair. *